Light-Sensitive GPCR Pathway Control via Wavelength Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling G-protein coupled receptor (GPCR) pathways are limited by the need for ligands and slow time courses, making it challenging to simultaneously or separately activate specific pathways in cellular systems, particularly in neuronal circuits and living animals.
Innovation Solution
Development of light-sensitive GPCRs with a light-sensitive extracellular domain and a heterologous intracellular domain that can modulate intracellular signaling pathways, allowing activation by different wavelengths and deactivation by distinct light wavelengths, enabling precise control of GPCR pathways in various cell types, including neurons.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If traditional ligand-based methods are used to control GPCR pathways, then pathway activation can be achieved, but the time course is slow and simultaneous activation of multiple pathways is difficult
Solution Approach 1:
The patent divides the control of GPCR pathways by using different wavelengths of light to activate different opsins, which in turn activate different G-protein pathways. Each opsin-GPCR construct is tuned to respond to a specific wavelength, allowing independent and simultaneous control of multiple pathways through wavelength-specific illumination.
Solution Approach 2:
The patent creates a universal light-controlled system where a single platform (opsin-based GPCR) can control multiple different signaling pathways (Gs, Gi, Gq) by simply changing the wavelength of light. This multi-functional system allows one system to perform multiple pathway activations without requiring separate ligand applications for each pathway.
2Ease of operation
If ligand-based activation of GPCRs is used, then pathway modulation is possible, but the method is invasive and lacks precision in temporal control
Solution Approach 1:
The patent replaces the chemical mechanism of ligand binding with an optical mechanism using light-activated opsins. Instead of applying chemical ligands that require diffusion, binding, and washout procedures, the system uses photons to directly activate the opsin domains, enabling non-invasive, rapid, and precisely temporally controlled pathway activation without the harmful effects of chemical interventions.
3Device complexity
If conventional GPCR activation methods are used, then signaling pathway modulation occurs, but separate activation of specific pathways requires multiple different ligands and procedures
Solution Approach 1:
The patent changes the control parameter from chemical ligand identity to physical light wavelength. By tuning the wavelength of light, different opsins with specific spectral sensitivities can be activated, providing reliable and specific activation of different G-protein pathways (Gs, Gi, Gq) without requiring multiple different chemical ligands and complex application procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables non-invasive, rapid, and precise modulation of neuronal activity and signaling pathways, facilitating the study of neural circuits and potential therapeutic applications by using light-activated switches like vertebrate rhodopsin and channelrhodopsin, and melanopsin variants for sustained or transient activations.
Implementation Method 1
a light-sensitive extracellular domain capable of being activated by light having a first wavelength
Implementation Method 2
Upon binding of a ligand to an extracellular portion of a GPCR, a signal is transduced within the cell that results in a change in a biological or physiological property of the cell
Data Source
AI summary
A light-sensitive G-protein coupled receptor includes a light sensitive extracellular cone opsin or melanopsin domain and a hetorologous intracellular domain capable of modulating an intracellular signaling pathway.


